Lilly, Pfizer, Sanofi lead in patent litigation, report says

Over a two year period from 2016 through 2017, 741 federal patent litigation cases were filed related to Food and Drug Administration Paragraph IV pharmaceutical Abbreviated New Drug Applications and 196 Patent Trial and Appeal Board petitions involving Orange Book patents, a new report from LexisNexis company Lex Machina said. During that same period, 843 ANDA cases and 246 patent board pharmaceutical trials were completed.